Clay B Siegall - Net Worth and Insider Trading
Clay B Siegall Net Worth
The estimated net worth of Clay B Siegall is at least $157 Million dollars as of 2024-05-15. Clay B Siegall is the President & CEO of Seagen Inc and owns about 666,060 shares of Seagen Inc (SGEN) stock worth over $152 Million. Clay B Siegall is the President and CEO of Immunome Inc and owns about 319,636 shares of Immunome Inc (IMNM) stock worth over $5 Million. Clay B Siegall is also the Director of Ultragenyx Pharmaceutical Inc and owns about 2,550 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $104,474. Besides these, Clay B Siegall also holds Alder BioPharmaceuticals Inc (ALDR) . Details can be seen in Clay B Siegall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Clay B Siegall has not made any transactions after 2023-10-02 and currently still holds the listed stock(s).
Transaction Summary of Clay B Siegall
Clay B Siegall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clay B Siegall owns 6 companies in total, including Seagen Inc (SGEN) , Ultragenyx Pharmaceutical Inc (RARE) , and Alder BioPharmaceuticals Inc (ALDR) among others .
Click here to see the complete history of Clay B Siegall’s form 4 insider trades.
Insider Ownership Summary of Clay B Siegall
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SGEN | Seagen Inc | 2022-05-12 | director & President and CEO |
RARE | Ultragenyx Pharmaceutical Inc | 2020-08-10 | director |
ALDR | Alder BioPharmaceuticals Inc | 2019-10-22 | director |
2015-09-30 | director | ||
2021-05-28 | director | ||
2023-10-02 | director & President and CEO |
Clay B Siegall Latest Holdings Summary
Clay B Siegall currently owns a total of 4 stocks. Among these stocks, Clay B Siegall owns 666,060 shares of Seagen Inc (SGEN) as of May 12, 2022, with a value of $152 Million and a weighting of 96.89%. Clay B Siegall owns 319,636 shares of Immunome Inc (IMNM) as of October 2, 2023, with a value of $5 Million and a weighting of 2.99%. Clay B Siegall also owns 2,550 shares of Ultragenyx Pharmaceutical Inc (RARE) as of August 10, 2020, with a value of $104,474 and a weighting of 0.07%. The other 1 stocks Alder BioPharmaceuticals Inc (ALDR) have a combined weighting of 0.05% among all his current holdings.
Latest Holdings of Clay B Siegall
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2022-05-12 | 666,060 | 228.74 | 152,354,564 |
IMNM | Immunome Inc | 2023-10-02 | 319,636 | 14.72 | 4,705,042 |
RARE | Ultragenyx Pharmaceutical Inc | 2020-08-10 | 2,550 | 40.97 | 104,474 |
ALDR | Alder BioPharmaceuticals Inc | 2015-05-18 | 4,444 | 18.88 | 83,903 |
Holding Weightings of Clay B Siegall
Clay B Siegall Form 4 Trading Tracker
According to the SEC Form 4 filings, Clay B Siegall has made a total of 40 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 40 sells. The most-recent trade in Seagen Inc is the sale of 17,043 shares on May 12, 2022, which brought Clay B Siegall around $2 Million.
According to the SEC Form 4 filings, Clay B Siegall has made a total of 1 transactions in Immunome Inc (IMNM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 169,204 shares on October 2, 2023, which cost Clay B Siegall around $999,996.
According to the SEC Form 4 filings, Clay B Siegall has made a total of 1 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 34,750 shares on August 10, 2020, which brought Clay B Siegall around $3 Million.
More details on Clay B Siegall's insider transactions can be found in the Insider Trading History of Clay B Siegall table.Insider Trading History of Clay B Siegall
- 1
Clay B Siegall Trading Performance
GuruFocus tracks the stock performance after each of Clay B Siegall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clay B Siegall is 34.27%. GuruFocus also compares Clay B Siegall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Clay B Siegall within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clay B Siegall's insider trading performs compared to the benchmark.
Performance of Clay B Siegall
Clay B Siegall Ownership Network
Ownership Network List of Clay B Siegall
Ownership Network Relation of Clay B Siegall
Clay B Siegall Owned Company Details
What does Seagen Inc do?
Who are the key executives at Seagen Inc?
Clay B Siegall is the director & President and CEO of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .
Seagen Inc (SGEN) Insider Trades Summary
Over the past 18 months, Clay B Siegall made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,447 shares made by Jean I Liu , a net sale of 46,232 shares made by Roger D Dansey , and a net sale of 161,013 shares made by Todd E Simpson .
In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 405,979 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 405,979 shares.
Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seagen Inc Insider Transactions
Clay B Siegall Mailing Address
Above is the net worth, insider trading, and ownership report for Clay B Siegall. You might contact Clay B Siegall via mailing address: 21823 30th Dr Se, Bothell Wa 98021.